Dozens of patients have filed transvaginal mesh lawsuits against a manufacturer of surgical mesh products. The lawsuits allege that the Avaulta transvaginal mesh —manufactured by C.R. Bard — caused them to experience severe, painful complications. More than 600 transvaginal mesh lawsuits have been filed so far.
Several plaintiffs are seeking to join a multi-district federal case against the company. Transvaginal mesh is used to treat pelvic organ prolapse, which occurs when the pelvic organs bulge through the interior walls of the vagina, and stress urinary incontinence.
The Food and Drug Administration has warned that transvaginal mesh users are at risk of additional complications not faced by women who undergo other types of surgical repair. Although the agency placed transvaginal mesh in its highest risk device category in response to these findings, the agency has not announced plans to issue a transvaginal mesh recall.